Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evoke Pharma (EVOK)
NASDAQ:EVOK
Evoke Pharma (EVOK) Stock Price & Analysis
434 Followers
EVOK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.40 - $1.77
Previous Close$0.47
Volume70.44K
Average Volume (3M)27.61K
Market Cap
$4.06M
Enterprise Value-$643.74K
Total Cash (Recent Filing)$9.70M
Total Debt (Recent Filing)$5.00M
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Aug 08, 2024EPS Estimate
-$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.83
Shares Outstanding8,597,405
10 Day Avg. Volume39,217
30 Day Avg. Volume27,608
Standard Deviation0.28
R-Squared0.00422
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.50
Price to Sales (P/S)3.13
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.11
Enterprise Value/Gross Profit-0.13
Enterprise Value/Ebitda0.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evoke Pharma News
Ownership Overview
51.96%
Insiders
0.66% Mutual Funds
36.07% Other Institutional Investors
11.31% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EVOK FAQ
What was Evoke Pharma’s price range in the past 12 months?
Evoke Pharma lowest stock price was $0.40 and its highest was $1.77 in the past 12 months.
What is Evoke Pharma’s market cap?
Currently, no data Available
When is Evoke Pharma’s upcoming earnings report date?
Evoke Pharma’s upcoming earnings report date is Aug 08, 2024 which is in 36 days.
How were Evoke Pharma’s earnings last quarter?
Evoke Pharma released its earnings results on May 14, 2024. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.21 by $0.04.
Is Evoke Pharma overvalued?
According to Wall Street analysts Evoke Pharma’s price is currently Overvalued.
Does Evoke Pharma pay dividends?
Evoke Pharma does not currently pay dividends.
What is Evoke Pharma’s EPS estimate?
Evoke Pharma’s EPS estimate is -$0.06.
How many shares outstanding does Evoke Pharma have?
Evoke Pharma has 8,597,405 shares outstanding.
What happened to Evoke Pharma’s price movement after its last earnings report?
Evoke Pharma reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.21. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evoke Pharma?
Currently, no hedge funds are holding shares in EVOK
---
Evoke Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.45%
12-Months-Change
Fundamentals
Return on Equity
-253.55%
Trailing 12-Months
Asset Growth
24.05%
Trailing 12-Months
Company Description
Evoke Pharma
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
---
EVOK Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---